Key facts
- Notable investors include SFC Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sonas Pharma
- ·The full record, as it builds
Funding rounds
No funding rounds for Sonas Pharma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sonas Pharma
Developer of cannabinoid medicines intended to focus on the research and development of pharmaceutical treatments for epilepsy and obesity. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Macclesfield, United Kingdom
- Founded
- 2023
- Employees
- 2
- Ownership
- Privately Held (backing)
Sonas Pharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sonas Pharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sonas Pharma in its N-PORT filings yet. We sweep new filings monthly.